ELI LILLY & Co is 52.4x more valuable than Roivant Sciences Ltd. by market capitalization ($1.070 T vs $20.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ROIV | LLY |
|---|---|---|
| Market cap | $20.43 B | $1.070 T |
| US-listed rank | #607 | #10 |
| Revenue (latest FY) | $8.26M | $65.18B |
| Net income (latest FY) | -$299.77M | $20.64B |
| Net margin | -3629.2% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 868 | 989 |
ELI LILLY & Co is 52.4x more valuable than Roivant Sciences Ltd. by market capitalization ($1.070 T vs $20.43 B).
In their latest fiscal years, Roivant Sciences Ltd. reported $8.26M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Roivant Sciences Ltd. and ELI LILLY & Co, or browse the full rankings.